Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000897069-23-001060
Filing Date
2023-08-02
Accepted
2023-08-02 17:55:32
Documents
2
Period of Report
2023-08-02

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 4629
2 kaplinpoa.htm EX-24.1 7360
  Complete submission text file 0000897069-23-001060.txt   13417
Mailing Address C/O AKERS BIOSCIENCES, INC. 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address
Kaplin Adam (Reporting) CIK: 0001858042 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41765 | Film No.: 231137310

Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 855 N WOLFE STREET #623-6 BALTIMORE MD 21205 813-369-5150
MIRA PHARMACEUTICALS, INC. (Issuer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
SIC: 2834 Pharmaceutical Preparations